OCI N.V. (OCI.AS)
Amsterdam, NL
OCI N.V. operates as an international producer and supplier of natural gas-derived products and industrial chemicals, catering to customers across the agricultural, transportation, and manufacturing industries. The company's activities are organized across various segments, specifically Methanol (covering both the US and Europe), Nitrogen (also with US and European operations), and Fertiglobe. Its comprehensive product range includes a variety of nitrogen-based compounds like anhydrous ammonia, granular urea, urea ammonium nitrate (UAN) solutions, calcium ammonium nitrate (CAN), ammonium sulphate, and nitric acid. Additionally, OCI N.V. offers specialized chemicals such as methanol (including bio-methanol), melamine, diesel exhaust fluid (DEF), and industrial gases like nitrogen argon and aqueous ammonia. A notable asset is its wholly-owned and operated ammonia export terminal situated in the port of Rotterdam. The company boasts a wide geographical presence, conducting business throughout Europe, the Americas, the Middle East, Africa, Asia, and Oceania. OCI N.V. also maintains a significant strategic alliance with the Abu Dhabi National Oil Company. Founded in 2013, the firm's corporate headquarters are located in Amsterdam, the Netherlands.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.27% | -3.86% | +3.72% | +3.31% | +10.00% | +22.22% | -51.62% | -82.01% | -82.07% | -71.08% | -90.47% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 7 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+11.4% ★ Q2'25: -42.7% (vs Q2'24)
-
EPS growth Chemicals - Specialty: +13.2%-96.3% Q2'25: -940.0% (vs Q2'24)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-35.1% Q2'25: -26.3% (vs Q2'24)
-
EBIT margin Chemicals - Specialty: +8.8%-28.5% Q2'25: -16.5% (vs Q2'24)
-
ROIC Chemicals - Specialty: +5.6%-25.5% Q2'25: -15.5% (vs Q2'24)
-
Share dilution Chemicals - Specialty: +0.1%-0.3% ★ Q2'25: +0.1% (vs Q2'24)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×-0.76× Q2'25: -1.71× (vs Q2'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 3 EPS Ana. |
Dec 2027 3 Rev. Ana. 3 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
6.13B
est: 5.98B (+2.5%)
|
2.69B
est: 2.66B (+1.1%)
|
2.19B
est: 2.28B (-3.9%)
|
1.91B
est: 1.88B (+1.3%)
|
2.25B
est: 2.03B (+11.1%)
|
3.25B
est: 3.28B (-0.8%)
|
3.03B
est: 3.09B (-1.9%)
|
3.47B
est: 3.28B (+5.8%)
|
6.32B
est: 6.22B (+1.7%)
|
3.71B
est: 9.55B (-61.1%)
|
1.96B
est: 2.10B (-6.4%)
|
975.10M
est: 1.63B (-40.3%)
|
1.09B
est: 1.07B (+1.9%)
|
1.10B
1.02B – 1.17B
+3.1% YoY
|
1.08B
874.21M – 1.27B
-1.9% YoY
|
909.41M
791.65M – 1.02B
-15.5% YoY
|
| EBITDA |
668.10M
est: 884.85M (-24.5%)
|
833.30M
est: 172.64M (+382.7%)
|
280.10M
est: -140.56M (+299.3%)
|
308.70M
est: 372.05M (-17.0%)
|
489.60M
est: 504.19M (-2.9%)
|
874.70M
est: -44.66M (+2,058.5%)
|
571.70M
est: -9.62M (+6,044.2%)
|
798.80M
est: -159.19M (+601.8%)
|
2.47B
est: -180.88M (+1,464.7%)
|
565.30M
est: -192.08M (+394.3%)
|
-144.00M
est: 134.46M (-207.1%)
|
38.90M
est: 104.88M (-62.9%)
|
-205.20M
est: 68.28M (-400.5%)
|
70.37M
65.20M – 75.13M
+3.1% YoY
|
69.00M
56.03M – 81.70M
-1.9% YoY
|
58.29M
50.74M – 65.54M
-15.5% YoY
|
| EBIT |
612.80M
est: 265.89M (+130.5%)
|
180.20M
est: 235.30M (-23.4%)
|
-21.50M
est: 186.49M (-111.5%)
|
465.50M
est: -47.93M (+1,071.2%)
|
116.10M
est: 339.21M (-65.8%)
|
449.60M
est: 220.78M (+103.6%)
|
27.00M
est: 494.92M (-94.5%)
|
206.60M
est: 110.11M (+87.6%)
|
1.58B
est: 125.12M (+1,160.3%)
|
387.30M
est: 132.86M (+191.5%)
|
-237.90M
est: -51.12M (-365.4%)
|
-68.20M
est: -39.87M (-71.0%)
|
-309.00M
est: -25.96M (-1,090.3%)
|
-26.76M
-28.56M – -24.79M
-3.1% YoY
|
-26.23M
-31.06M – -21.30M
+1.9% YoY
|
-22.16M
-24.92M – -19.29M
+15.5% YoY
|
| Net Income |
295.20M
est: 295.46M (-0.1%)
|
328.70M
est: 131.08M (+150.8%)
|
384.70M
est: 284.32M (+35.3%)
|
167.90M
est: 319.55M (-47.5%)
|
-103.60M
est: 187.04M (-155.4%)
|
-48.70M
est: -154.23M (+68.4%)
|
-300.20M
est: -47.79M (-528.1%)
|
-177.70M
est: -350.98M (+49.4%)
|
570.50M
est: -398.82M (+243.0%)
|
1.24B
est: 188.90M (+555.1%)
|
-392.00M
est: -803.96M (+51.2%)
|
4.98B
est: -67.06M (+7,524.7%)
|
183.70M
est: 598.51M (-69.3%)
|
13.73M
-120.07M – 43.66M
-97.7% YoY
|
-453.9K
-529.1K – -378.8K
-103.3% YoY
|
2.62M
2.18M – 3.05M
+677.9% YoY
|
| SGA |
434.40M
est: 645.87M (-32.7%)
|
265.10M
est: 90.10M (+194.2%)
|
270.30M
est: 229.31M (+17.9%)
|
224.10M
est: 224.52M (-0.2%)
|
160.90M
est: 165.87M (-3.0%)
|
177.60M
est: 197.85M (-10.2%)
|
219.10M
est: 168.61M (+29.9%)
|
219.30M
est: 209.52M (+4.7%)
|
266.40M
est: 238.08M (+11.9%)
|
372.50M
est: 252.81M (+47.3%)
|
188.90M
est: 266.28M (-29.1%)
|
231.90M
est: 207.70M (+11.7%)
|
171.70M
est: 135.22M (+27.0%)
|
139.37M
129.12M – 148.79M
+3.1% YoY
|
136.65M
110.96M – 161.79M
-1.9% YoY
|
115.43M
100.48M – 129.80M
-15.5% YoY
|
| EPS |
1.45
est: 1.40 (+3.8%)
|
1.60
est: 1.22 (+30.7%)
|
1.84
est: 0.24 (+652.3%)
|
0.80
est: 0.17 (+380.7%)
|
-0.50
est: 0.05 (-1,105.5%)
|
-0.23
est: 0.04 (-689.5%)
|
-1.43
est: -0.11 (-1,194.7%)
|
-0.85
est: -0.10 (-761.2%)
|
2.72
est: 0.39 (+591.9%)
|
-4.15
est: 1.07 (-489.4%)
|
-2.69
est: -3.82 (+29.5%)
|
23.59
est: -0.32 (+7,496.6%)
|
0.84
est: 0.93 (-9.5%)
|
-0.08
-0.57 – 0.21
-108.6% YoY
|
0.00
0.00 – 0.00
+97.3% YoY
|
0.01
0.01 – 0.01
+676.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-28 | C | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-27 | C | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-26 | C | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-25 | C | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-22 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-21 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-20 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-19 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-18 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-15 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-14 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares Agribusiness UCITS ETF ISAG.L | 0.19% | 876.5K | 0.55% |
| 2 | iShares MSCI Netherlands ETF EWN | 0.12% | 632.9K | 0.50% |
| 3 | iShares MSCI Agriculture Producers ETF VEGI | 0.08% | 118.1K | 0.39% |
| 4 | UBS MSCI EMU Small Cap UCITS ETF EUR dis UEFD.DE | 0.07% | 484.1K | 0.33% |
| 5 | iShares MSCI EMU Small Cap UCITS ETF CES1.L | 0.06% | 673.1K | 0.58% |
| 6 | Amundi MSCI EMU Small Cap ESG Broad Transition UCITS ETF Dist MMS.PA | 0.04% | 281.3K | 0.40% |
| 7 | Schwab Fundamental International Small Company Index ETF FNDC | 0.04% | 1.18M | 0.39% |
| 8 | State Street SPDR MSCI Europe Small Cap Value Weighted UCITS ETF EUR Acc ZPRX.DE | 0.03% | 222.3K | 0.30% |
| 9 | iShares MSCI Europe Small-Cap ETF IEUS | 0.03% | 45.1K | 0.41% |
| 10 | Xtrackers MSCI Europe Small Cap UCITS ETF 1C XXSC.L | 0.03% | 871.1K | 0.30% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Salman Khalid Butt | Advisor | 3M | male |
| Hassan Hossam Hassan Badrawi | Chief Executive Officer | 1M | male |
| Nassef Onssy Naguib Sawiris | Executive Chairman | 900.8K | male |
| Maud C. de Vries | Chief Legal & Human Capital Officer | 553.9K | female |
| Beshoy Guirguis | Chief Financial Officer & Executive Director | — | male |
| Sarah Rajani | Global Vice President of Investor Relations & Communications | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for OCI.AS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
